Intrapericardial Delivery of Gelfoam Enables the Targeted Delivery of Periostin Peptide after Myocardial Infarction by Inducing Fibrin Clot Formation
Open Access
- 10 May 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (5) , e36788
Abstract
Administration of a recombinant peptide of Periostin (rPN) has recently been shown to stimulate cardiomyocyte proliferation and angiogensis after myocardial infarction (MI) [1]. However, strategies for targeting the delivery of rPN to the heart are lacking. Intrapericardial administration of drug-eluting hydrogels may provide a clinically viable strategy for increasing myocardial retention, therapeutic efficacy, and bioactivity of rPN and to decrease systemic re-circulation. We investigated the ability of intrapericardial injections of drug-eluting hydrogels to deliver and prolong the release of rPN to the myocardium in a large animal model of myocardial infarction. Gelfoam is an FDA-approved hemostatic material commonly used in surgery, and is known to stimulate fibrin clot formation. We show that Gelfoam disks loaded with rPN, when implanted within the pericardium or peritoneum of mammals becomes encapsulated within a non-fibrotic fibrin-rich hydrogel, prolonging the in vitro and in vivo release of rPN. Administration into the pericardial cavity of pigs, following a complete occlusion of the left anterior descending artery, leads to greater induction of cardiomyocyte mitosis, increased cardiomyocyte cell cycle activity, and enhanced angiogenesis compared to direct injection of rPN alone. The results of this study suggest that intrapericardial drug delivery of Gelfoam, enhanced by triggered clot formation, can be used to effectively deliver rPN to the myocardium in a clinically relevant model of myocardial infarction. The work presented here should enhance the translational potential of pharmaceutical-based strategies that must be targeted to the myocardium.Keywords
This publication has 37 references indexed in Scilit:
- Delivery of gelfoam-enabled cells and vectors into the pericardial space using a percutaneous approach in a porcine modelGene Therapy, 2011
- Roles of epithelial cell-derived periostin in TGF-β activation, collagen production, and collagen gel elasticity in asthmaProceedings of the National Academy of Sciences, 2010
- Protein Therapeutics for Cardiac Regeneration after Myocardial InfarctionJournal of Cardiovascular Translational Research, 2010
- Spatiotemporal controlled delivery of nanoparticles to injured vasculatureProceedings of the National Academy of Sciences, 2010
- The many facets of the matricelluar protein periostin during cardiac development, remodeling, and pathophysiologyJournal of Cell Communication and Signaling, 2009
- Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responsesMucosal Immunology, 2008
- Periostin is essential for cardiac healingafter acute myocardial infarctionJournal of Experimental Medicine, 2008
- Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroidsProceedings of the National Academy of Sciences, 2007
- Genetic Manipulation of Periostin Expression Reveals a Role in Cardiac Hypertrophy and Ventricular RemodelingCirculation Research, 2007
- FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarctionProceedings of the National Academy of Sciences, 2006